These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 10051493)

  • 21. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
    Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
    J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroepidemiology of hepatitis A in patients with chronic liver disease.
    Saab S; Lee C; Shpaner A; Ibrahim AB
    J Viral Hepat; 2005 Jan; 12(1):101-5. PubMed ID: 15655056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects.
    Bayram A; Ozkur A; Erkilic S
    J Clin Virol; 2009 Jul; 45(3):212-7. PubMed ID: 19497785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
    Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
    Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
    Kaya S; Cicioğlu Aridoğan B; Demirci M
    Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus antibodies in chronic liver diseases of different aetiology.
    Craxi A; Almasio P; Di Marco V; Magrin S; Bruno R; Cammà C; Fiorentino G; Lo Jacono O; Marino L; Palazzo U
    Ital J Gastroenterol; 1991 Jun; 23(5):244-8. PubMed ID: 1742513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
    Stroffolini T; Sagnelli E; Mele A; Cottone C; Almasio PL;
    J Viral Hepat; 2007 Sep; 14(9):618-23. PubMed ID: 17697013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study.
    Bedogni G; Miglioli L; Masutti F; Ferri S; Castiglione A; Lenzi M; Crocè LS; Granito A; Tiribelli C; Bellentani S
    Am J Gastroenterol; 2008 Sep; 103(9):2248-53. PubMed ID: 18637095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [GBV-C/HGV, a new virus as one possible cause of hepatitis of unknown etiology].
    König J; Summerová M; Kaslíková J; Svejda J; Strakrle V; Gregora E; Nĕmecek V; Procházka B; Rozprimová L; Rocková R
    Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):103-10. PubMed ID: 11550417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
    Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
    J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990-2002.
    Vogt TM; Goldstein ST; Kuartei S
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1130-4. PubMed ID: 16765396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis viruses and chronic liver disease.
    Tangkijvanich P; Theamboonlers A; Hirsch P; Thongngam D; Kullavanijaya P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):489-95. PubMed ID: 10774657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral hepatitis in India.
    Acharya SK; Madan K; Dattagupta S; Panda SK
    Natl Med J India; 2006; 19(4):203-17. PubMed ID: 17100109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis and HIV infection during haemodialysis.
    Saha D; Agarwal SK
    J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.
    Bell BP; Manos MM; Zaman A; Terrault N; Thomas A; Navarro VJ; Dhotre KB; Murphy RC; Van Ness GR; Stabach N; Robert ME; Bower WA; Bialek SR; Sofair AN
    Am J Gastroenterol; 2008 Nov; 103(11):2727-36; quiz 2737. PubMed ID: 18684170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection.
    Sagnelli E; Coppola N; Pisaturo M; Pisapia R; Onofrio M; Sagnelli C; Catuogno A; Scolastico C; Piccinino F; Filippini P
    Clin Infect Dis; 2006 Jun; 42(11):1536-43. PubMed ID: 16652310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus.
    Lacombe K; Boyd A; Desvarieux M; Serfaty L; Bonnord P; Gozlan J; Molina JM; Miailhes P; Lascoux-Combe C; Gault E; Girard PM
    AIDS; 2007 Nov; 21(18):2546-9. PubMed ID: 18025897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.